Sensex-Nifty
Covid-19 vaccines approval spikes Sensex to new high
Mumbai/UNI: The benchmark Sensex rallied 307.82 points on Monday and closed at an all time high 48,176.80 as the investors' sentiments were lifted over emergency approval of two Covid-19 vaccines in India.
The Sensex registered 0.6 per cent increase, while Nifty jumped by 0.82 pc to close at record 14,132.90.
ONGC was the top gainer, rising around 4 per cent, followed by TCS, HCL Tech, Tech Mahindra, Infosys, M&M, HUL and L&T.
On the other hand, Kotak Bank, Bajaj Finance, Asian Paints, Titan and PowerGrid were among the laggards.
India, which has the second-highest Covid-19 infections in the world, on Sunday approved for emergency use two coronavirus vaccines – one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech.
The country is expected to start a massive immunisation program shortly. Serum Institute of India, the local maker of the AstraZeneca/Oxford vaccine.
In global markets, stock exchanges in Europe as well as in Shanghai, Seoul and Hong Kong ended on a positive note.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
